Operating Lease, Right-of-Use Asset in USD of SQZ Biotechnologies Co from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
SQZ Biotechnologies Co quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2019 to Q3 2023.
  • SQZ Biotechnologies Co Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2023 was $14.4M, a 76.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

SQZ Biotechnologies Co Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $14.4M -$48M -76.9% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $22.5M -$42.4M -65.3% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $24.6M -$42.8M -63.5% 31 Mar 2023 10-Q 10 May 2023
Q4 2022 $27.4M -$42.4M -60.7% 31 Dec 2022 10-Q 08 Nov 2023
Q3 2022 $62.4M -$9.9M -13.7% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $65M +$21.5M +49.4% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $67.4M +$21.5M +46.8% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $69.8M +$21.5M +44.4% 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 $72.3M +$21.5M +42.3% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $43.5M 30 Jun 2021 10-Q 04 Aug 2021
Q1 2021 $45.9M 31 Mar 2021 10-Q 11 May 2021
Q4 2020 $48.4M +$5.31M +12.3% 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 $50.8M 30 Sep 2020 10-Q 10 Dec 2020
Q4 2019 $43.1M 31 Dec 2019 10-K 18 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.